Patents by Inventor Jared Jagdeo

Jared Jagdeo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for in vitro inhibition of fibroblast proliferation
    Patent number: 9861832
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: January 9, 2018
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov
  • SYSTEM AND METHOD OF COMBINED TISSUE IMAGING AND IMAGE-GUIDED LASER THERAPY
    Publication number: 20160317226
    Abstract: A system and method for combined tissue imaging and image-guided laser therapy is provided. The apparatus has one or more imaging modalities and lasers that are controlled by a controller. The setting configuration of the laser is determined by the location of designated boundaries and the structures of the target tissue that have been imaged. Intra-operative imaging of the target tissue allows a real time evaluation of the laser administration and determines the laser configuration if the contemporary images indicate a re-treatment is necessary. Over treatment and under treatment by the laser is avoided by image-directed laser ablation or non-ablative laser therapy.
    Type: Application
    Filed: May 4, 2016
    Publication date: November 3, 2016
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jared Jagdeo, Andrew Mamalis
  • METHODS FOR IN VITRO INHIBITION OF FIBROBLAST PROLIFERATION
    Publication number: 20140277293
    Abstract: Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicants: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Jared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov